
Eli Lilly and Company ir starptautisks farmācijas un veselības aprūpes uzņēmums, kas koncentrējas uz recepšu medikamentu atklāšanu, izstrādi, ražošanu un komercializāciju. Uzņēmuma darbība aptver tādas terapeitiskās jomas kā diabēts, onkoloģija, imunoloģija, neirozinātne un sāpju ārstēšana, apvienojot pētniecību un izstrādi ar klīniskajiem pētījumiem, regulatīvajiem procesiem, bioloģisko un mazo molekulu zāļu ražošanu un izplatīšanu visā pasaulē.
Director of Translational Pharmacokinetics (DMPK)
Lead PBPK and PKPD modeling and first-in-human dose projections for orexin medicines, supporting clinical development, dosing decisions, and regulatory submissions.
Apraksts
- Build and validate PBPK models for ADME and drug interactions.
- Develop PKPD models using nonclinical and clinical evidence.
- Project first-in-human doses for candidates entering clinical development.
- Analyze and integrate nonclinical, clinical, and other experimental data into models.
- Prepare simulation reports and evidence for regulatory decisions and submissions, including INDs, CTAs, IBs, briefings, responses, and health authority meetings.
- Contribute to regulatory interactions and related preparation.
- Work with DMPK, clinical pharmacology, translational sciences, CMC, clinical development, regulatory affairs, and project management teams.
- Advise on in vitro and in vivo study designs for model development.
- Run drug interaction simulations and refine dosing strategies across physiological conditions.
- Support candidate selection and transitions from research to development.
- Assess emerging science and competitive developments.
- Present program recommendations to senior leaders and governance committees.
- Mentor early-career scientists and help build organizational capabilities.
- Advance scientific rigor, innovation, and operational excellence across the portfolio.
Prasības
- Hold a PhD, PharmD, or equivalent advanced scientific degree.
- Bring at least 12 years of industry experience in PBPK and PKPD modeling and simulation, including first-in-human dose projections.
- Demonstrate experience supporting IND-enabling programs and regulatory submissions.
- Understand ADME principles.
- Use pharmacokinetic modeling tools such as Simcyp, GastroPlus, Phoenix WinNonlin, and NONMEM.
- Critically assess experimental data for model inputs.
- Work effectively in a highly collaborative, matrixed biotechnology setting.
- Have experience with CNS, neuroscience, rare disease, or sleep-wake disorder programs.
- Know FDA, EMA, and ICH regulatory requirements.
- Advance programs from candidate selection through clinical development.
- Manage CRO networks and outsourced development work.
- Apply strategic thinking and sound scientific judgment.
- Communicate and influence effectively.
- Lead across functions.
- Manage projects and risks effectively.
- Balance scientific rigor with operational delivery.
- Bring a collaborative, hands-on leadership approach.
- Adapt readily and learn quickly.
Priekšrocības
- Company bonus, based in part on company and individual performance.
- Company-sponsored 401(k) plan.
- Pension.
- Vacation benefits.
- Medical, dental, vision, and prescription drug coverage.
- Flexible benefits, including healthcare and/or dependent day care flexible spending accounts.
- Life insurance and death benefits.
- Time off and leave of absence benefits.
- Well-being support, including an employee assistance program, fitness benefits, and employee clubs and activities.
- Employee resource groups and support networks.
Saistītās vakances
Nav atrasts neviens darbs
Mēģiniet pielāgot vai notīrīt filtrus, lai atrastu vairāk iespēju.